Status:

COMPLETED

Impact of Periodontal Therapy on Patients With Diabetes

Lead Sponsor:

State University of New York at Buffalo

Collaborating Sponsors:

Sunstar, Inc.

Conditions:

Diabetes Mellitus, Type II

Periodontitis

Eligibility:

All Genders

25+ years

Phase:

PHASE2

Brief Summary

With poorly controlled diabetes, periodontal status often worsens, and with severe periodontal conditions there is often poorer glycemic control. There are few published reports investigating the effi...

Detailed Description

With poorly controlled diabetes, periodontal disease worsens, and with severe periodontal conditions, there is often poorer glycemic control. Published papers conclude that periodontal treatment leads...

Eligibility Criteria

Inclusion

  • Be able to understand the informed consent form and be willing and able to read and sign it.
  • At least 25 years of age.
  • Be able to understand and follow directions for study procedures.
  • At least 14 natural teeth, not counting third molars ("wisdom teeth").
  • At least 2 interproximal sites with CAL \>= 4 mm or at least 2 interproximal sites with PD \>= 5 mm.

Exclusion

  • Presence of orthodontic appliances ("braces").
  • An abnormal condition of lips, lining of the mouth, tongue, or gums (except for periodontal disease). If subject has a cold sore, canker sore, or injury in their mouth, they may return after the sore or injury heals.
  • Abscess of the gingiva caused by periodontal disease, or visible gross tooth decay
  • A broken tooth root or an abscessed tooth. Subject may be allowed to participate in the study after the condition is successfully treated.
  • Periodontal treatment or antibiotic therapy in the past 6 months.
  • Have used cigarettes or other tobacco products in the past year.
  • Body mass index (BMI) is \> 40.
  • Have regularly used non-steroidal anti-inflammatory drugs (such as \>= 325 mg aspirin or ibuprofen) over the past 3 weeks.
  • Regularly using drugs that weaken the immune system (such as corticosteroids taken by mouth or injection, and cyclosporine).
  • Have participated in another clinical research study in the past 30 days.
  • Pregnant or breastfeeding.
  • Have a condition that we feel will make study participation unsafe or difficult for the patient.
  • Require premedication for dental exams.

Key Trial Info

Start Date :

November 8 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 28 2021

Estimated Enrollment :

116 Patients enrolled

Trial Details

Trial ID

NCT04830969

Start Date

November 8 2016

End Date

January 28 2021

Last Update

March 1 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University at Buffalo

Buffalo, New York, United States, 14214